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INTRODUCTION 
The urinary framework is comprised of two significant 
bean-molded kidneys, ureters, bladder, and urethra. 
These bean-formed kidneys are found only at the center 
of the back and beneath the sets of ribs. The kidney 
transports water and squanders from the flowing blood 
and converts it to form urine (Aune et al., 2018). These are 
likewise helpful for making an equilibrium balance of 
salts and different ions in the blood. The tubes of the 
urethras, which are restricted in size, convey urine 
creation from the kidneys, which transport it to a triangle-
shaped chamber called the bladder (Fisang et al., 2015). 
Simultaneously, urine is put away in a versatile inflatable 
sort chamber called bladder, which gets straightened 
when urine is expelled through the urethra out the body. 
The term 'Urolithiasis' is a worldwide issue influencing 
human beings, called 'Nephrolithiasis' or kidney stones. 
Urolithiasis is a condition in which the crystals of 
uroliths/stones present in the urinary tract are 
summarized in Figure 1 (Abdel-Daim et al., 2017). In the 
Conventional world, the yearly frequency of urolithiasis 
has been about 0.5% with a lifetime risk of creating is 
about 10-15%, yet its increment with 20-25% in the  
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 Abstract 
Kidney and urinary stone disease (Nephrolithiasis and urolithiasis) 
are the condition where urinary stones or calculi are formed in the 
urinary tract. The problem of urinary stones is very ancient; these 
stones are found in all parts of the urinary tract, kidney, ureters, and 
the urinary bladder and may vary considerably in size. It is a common 
disease estimated to occur in approximately 12% of the population, 
with a recurrence rate of 70-81% in males and 47-60% in females. The 
treatment of kidney and urinary stone diseases such as a western 
(allopathy) medicine and surgery is now in trends. However, most 
people preferred plant-based (herbal) therapy because of the overuse 
of allopathic drugs, which results in a higher incidence rate of adverse 
or severe side effects. Therefore, people every year turn to herbal 
therapy because they believe plant-based medicine is free from 
undesirable side effects, although herbal medicines are generally 
considered to be safe and effective. In the present article, an attempt 
has been made to emphasize an herbal therapy is better than allopathic 
therapy for the management of the kidney and urinary stone disease. 
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Middle East. Urolithiasis is the arrangement of uneven 
calculi or the condition which has a place with urinary 
calculi (Ahmed et al., 2015). The condition of calculi is 
synonymous with the term uroliths, stones, or crystals. 
These calculi are made of polycrystalline totals made out 
of the crystalloid and organic matrix (Han et al., 2015). 
These calculi can fit as a fiddle and find any place in the 
urinary tract from the kidney to the bladder (Arya et al., 
2017). 
 
Figure 1. Locations of kidney and urinary stones in the urinary 
tract (Rodgers et al., 2016). 
 
A kidney stone is a group of crystals formed together to 
make a hard lump in both kidneys. They can shift in size 
from a few millimeters to several centimeters. Most of the 
stones will drop off the urine body, with no assistance, yet 
some will require intervention to expel them (Jung & 
Osther, 2015). The urinary stones have been created with 
the crystals of phosphate, uric acid, magnesium 
ammonium phosphate with apatite, and struvite. 
Among the urinary stones, calcium-containing stones 
have been found about 75% of every single urinary 
calculi, which might be available as crystals of 
unadulterated Calcium oxalate (CaC2O4) 50%, calcium 
phosphate 5%, and a mixture of both compounds 45% 
(Ferraro et al., 2017). The diet can influence the 
concentration of specific substances in the urine and 
influence urine acidity. The 24 hours assortment of urine 
may find any given properties have expanded the risk of 
forming stones enlisted in Table I (Aziz & Hassan, 2020). 
Calcium oxalate, uric acid, and citrate are typical 
substances found in the blood (Khan, 2016). The acidity 
of any liquid is expressed as pH. The pH of < 7 is acidic, 
while pH > 7 is alkaline (Coe et al., 2016). The normal 
urine pH will change during the day, rely upon diet, and 
usually range between 5 and 8. Calcium oxalate stones 
can be found in any pH of urine. The development of uric 
acid stones is more in acidic urine, while calcium 
phosphate forms in more alkaline urine (Cakıroğlu et al., 
2016). 
Table I. Salt composition of the kidney (Chen et al., 2018) 
Term Descriptions 
Hypocitraturia Low levels of citrate 
Hypercalciuria High levels of calcium 
Hyperuricemia High levels of uric acid 
Hyperoxaluria High levels of oxalate 
 
The chemical composition of kidney stones depends on 
the abnormalities in the urine composition of various 
chemicals. Human kidney stones are commonly 
classified into five types, as follows in Table II (Albert et 
al., 2017). 
Table II. Five types of kidney and urinary stones and their 
descriptions (Kummer et al., 2015) 
Stones Descriptions 
Urate or uric acid 
stone 
Uric acid stones are formed due to low 
urine output, excessive intake of 
proteins, especially red meat. These 
form in acidic urine and are not visible in 
a plain X-Ray (Giardina et al., 2014). 
Calcium stone These are composed of calcium 
compounds, mostly CaC2O4. 
Sometimes other minerals such as 
calcium phosphate may also form 
stones. Calcium stones may be caused 
by Hypercalciuria, such as in 
Hyperparathyroidism (Holmes et al., 
2016). 
Struvite or 
Magnesium 
ammonium 
phosphate stone 
These types of stones are usually 
associated with urinary infection. They 
can grow very rapidly forming cast in 
the urinary tract (Staghorn calculus). 
Left untreated, these may cause chronic 
infection and permanent kidney 
damage (Kanlaya et al., 2016). 
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Cystine stone These occur due to an inherited defect in 
amino acid transport, manifests as 
recurrent stones in young patients 
Drug-Induced stone This accounts for about 1% of all stone 
types. Drugs such as guaifenesin, 
triamterene, atazanavir, and sulphas 
drugs induce these stones (Bultitude et 
al., 2016). 
 
In this mini-review, we will discuss the various 
advantages of herbal medicines, especially those used in 
ayurvedic therapy, compared to the use of various 
allopathic drugs to manage kidney and urinary stones 
disease. The advantages discussed are mainly from the 
side effects that occur from the use of these drugs. In 
addition, several things related to kidney and urinary 
stones disease will also be discussed, including 
epidemiology, pathophysiology, symptoms, diagnosis, 
and prevention. 
 
EPIDEMIOLOGY 
Globally, kidney and urinary stones disease 
pervasiveness and repeat rates are expanding, with 
limited choices of effective drugs (Evan et al., 2015). 
Urolithiasis influences about 12% of the total population 
at some phase in their lifetime. It influences all ages, 
genders, and races. However, it happens more now and 
again than in women aged 20-49 years (Chauveau et al., 
2018). If patients do not make a difference metaphylaxis, 
the backsliding pace of secondary stone developments is 
assessed to be 10-23% every year, 50%  in 5-10 years, and 
75% in 20 years (Green & Ratan, 2013). In any case, the 
lifetime repeat rate is higher in males, even though 
nephrolithiasis is developing among females. 
Subsequently, prophylactic management is of great 
importance to manage kidney stones (Daudon et al., 
2018). Ongoing investigations have revealed that 
urolithiasis' predominance has been expanding in the 
previous decades in both developed and developing 
countries (Duan et al., 2020). This development pattern is 
accepted to be related to changes in the way of lifestyle 
modifications, for example, the absence of physical action 
and dietary propensities and global warming. In the 
United States, kidney stones influence 1 of every 11 
individuals, and it is assessed that 600,000 Americans 
experience the ill effects of urinary stones each year. In the 
Indian population, about 12% of them are relied upon to 
have urinary stones, and out of which, 50% may end up 
with the loss of kidney capacities (Cloutier et al., 2015). 
 
PATHOPHYSIOLOGY 
The pathophysiology of kidney stones is not yet fully 
understood. Despite increasing study in the last decade, 
the mechanisms whereby CaC2O4 crystals are retained in 
the kidney and form renal stones remain (Gambaro et al., 
2017). The formation of stone required supersaturated 
ionic urine, summarized in Figure 2. The level of 
supersaturation is also dependent on urinary pH, ionic 
strength, solute concentration in the urine, and 
complications (Gambaro et al., 2016). Three conditions 
must coexist for the formation of struvite calculi:  
1. An alkaline pH of urine 
2. The presence of urea or ammonia in the urine  
3. A high amount of minerals in the urine. 
 
Figure 2. The formation process of stones in kidney and 
urinary tract (Ferraro et al., 2019). 
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SYMPTOMS 
Stones in the kidney frequently do not cause any signs 
and symptoms and can go undiagnosed. At the point 
when a stone leaves the kidney, it goes to the bladder 
through the ureter. Regularly the stone can become 
stopped in the ureter (Khan et al., 2016). When the stone 
obstructs urine progression out of the kidney, it can make 
the kidney swell (hydronephrosis), regularly causing 
much pain. Common symptoms of kidney stones are:  
1. Sharp, squeezing torment in the back and side, 
regularly moving to the lower abdomen or groin 
(Smith-Bindman et al., 2014). Some female says the 
pain is worse than childbirth labor pains. The pain 
frequently begins all of a sudden and comes in waves. 
It can come and go as the body tries to get rid of the 
stone (Afsar et al., 2016) 
2. A feeling of intense need to urinate 
3. Urinating more often or a burning feeling during 
urination 
4. Urine is dark or red due to blood. Sometimes urine 
has only small amounts of red blood cells that cannot 
be seen with the naked eye (Hollingsworth et al., 2016) 
5. Men may feel pain at the tip of their penis (Das & 
Malipeddi, 2016). 
 
DIAGNOSIS 
Diagnosis of kidney and urinary stones requires a 
complete health history assessment, laboratory or 
imaging tests, and a physical exam. Other tests include in 
Table III (Courbebaisse et al., 2017). 
Table III. Nephrologist uses diagnostic tests of kidney and 
urinary stones and their descriptions 
Tests Descriptions 
Blood testing Blood tests measure too much calcium or uric 
acid in the blood. Blood test results help 
monitor the kidney's health and may lead the 
nephrologist to check for other medical 
conditions (Zhu et al., 2014). 
Urine testing The 24-hours urine collection test may show 
that the kidney is excreting too many stones-
forming minerals or too few stones preventing 
substances. For this test, the nephrologist may 
request to perform two urine collections over 
two consecutive days (Ragettli et al., 2017). 
Imaging test Imaging tests may show the availability of 
kidney stones in the urinary tract. Options 
range from simple abdominal X-rays, which 
can miss small kidney stones, to high-speed or 
dual energy computerized tomography (CT) 
that capture even tiny stones (Kapoor et al., 
2017). 
Other imaging 
options 
An ultrasound, a non-invasive test, and 
intravenous urography, which involves 
injecting dye into an arm vein and taking X-
rays (intravenous pyelogram) or obtaining CT 
images (CT urogram) as the dye travels 
through the kidneys and the bladder 
(Nirumand et al., 2018). 
 
TREATMENT 
Herbal medicine 
According to the World health organization estimate, 
80% population living in developing countries almost 
exclusively uses herbal medicines. This means that 3,330 
million people use herbal medicines regularly 
(Sharifiyan et al., 2016). Ayurveda, an indigenous system 
of Indian medicine, offers immense extensions of the 
successful treatment of kidney stones disease described 
in Table IV (Tavasoli et al., 2020). 
Table IV. List of herbal drugs used in the treatment of kidney 
and urinary stones 
Scientific name 
(Family) 
Common 
name 
Mode of intake and use 
Zea mays (Poaceae) Corn, 
Makka 
The decoction of the female 
inflorescence or immature cobs 
are orally administered to expel 
the kidney stones; Dose: two 
times a day for seven days 
(Pathan et al., 2018). 
Aegle marmelose 
(Rutaceae) 
Bael, Bilwa Dried fruit pulp powder is 
given orally with coconut milk 
to dissolve kidney stones; Dose: 
a teaspoon powder with 100 ml 
of coconut milk taken two 
times a day for 14 days (Unno 
et al., 2020). 
Cynodon dactylon 
(Poaceae) 
Garika 
gaddi 
The whole plant extract was 
given orally to dissolve kidney 
stones; Dose: 10-20 ml extract 
taken two times a day for ten 
days. 
Strychnos 
potatorum 
(Loganiaceae) 
Chilla 
ginjalu 
The decoction of roots taken 
orally to dissolve and expel 
kidney stones; Dose: a teacup 
decoction taken two times a 
day for 20 days (Yiu et al., 2015). 
Tribulus terrestis 
(Zygophyllaceae) 
Gokharu, 
Devil's-
thorn 
Fruits and root decoction are 
given orally to be used to treat 
kidney stones; Dose: three 
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times a day is taken regularly 
for 14 days. 
Tinospora cordifolia 
(Menispermaceae) 
Guduchi, 
Giloy 
Crushed stem powder is given 
orally to expel the kidney 
stones; Dose: 5 g taken daily for 
14 days (Spatola et al., 2018). 
Celosia argentea 
(Amaranthaceae) 
Gunugu Dried seeds powder is orally 
administered to dissolve 
kidney stones; Dose: 1 g 
powder taken one time a day 
for five days. 
Phyllanthus 
fraternus 
(Euphorbiaceae) 
Gulf leaf-
flower, Bhoi 
amli 
Fresh plant extract pounded 
with pepper and turmeric 
extract is administered orally to 
dissolve the stones; Dose: 2 g 
taken daily for five days (Wang 
et al., 2016). 
Bryophyllum 
pinnatum Oken. 
(Crassulaceae) 
Patharchata, 
Ajjuba, 
Ghavpatta 
Fresh leaf juice and kalimirch 
powder are given orally to 
dissolve and expel kidney 
stones; Dose: Taken two times 
a day for 15 days. 
Boerhaavia diffusa 
(Nyctaginaceae) 
Bishkapra, 
Punarnava 
The root decoction is orally 
administered to expel kidney 
stones; Dose: Taken daily for a 
month (Türk et al., 2016). 
 
Allopathic medicine 
Patients with kidney and urinary stones, a nephrologist 
may also prescribe allopathic medicines to prevent future 
kidney stones (Wijarnpreecha et al., 2018). Depending on 
the 24-hour urine collection result, there are different 
treatment options for different kidney stones types 
(Vicedo-Cabrera et al., 2020). Now there is convincing 
evidence that by treating specific biochemical 
abnormalities, the recurrence rate can be reduced. 
Commonly three classes of allopathic medications used 
for kidney and urinary stones management are enlisted 
in Table V (Ross et al., 2018). 
Table V. Treatment of kidney and urinary stones with 
conventional (allopathic) medicines 
Classes Drugs Uses 
Side 
effects 
Sulphonamide 
derivatives 
Zonisamide Ailments of 
kidney and 
urinary stone 
Lightheaded-
ness, 
shortness of 
breath, rapid 
heart rate, 
trouble 
concentrating 
and fever 
(Pozdzik et 
al., 2019). 
Bisphosphonate Etidronate 
disodium 
Kidney 
stones 
Stomach 
upset or 
diarrhea, 
muscle pain, 
mood 
changes, and 
allergic 
reactions 
(rash, 
itching). 
Cardiac 
glycoside 
Digoxin Ailments of 
kidney and 
urinary 
stones 
Skin rash, 
itching, 
blurred 
vision, 
anxiety, 
depression, 
and severe 
stomach pain 
(Prabhu et al., 
2016). 
Bile acid 
sequestrates 
Cholestyramine Kidney 
diseases 
Unusual 
bleeding/ 
bruising, 
rapid 
breathing, 
confusion, 
vomiting, 
and loss of 
appetite 
(Skolarikos et 
al., 2015). 
Analogue of 
hypoxanthine 
Allopurinol Treatment of 
urinary 
infections and 
calculi 
Persistent 
nausea/ 
vomiting, 
dark urine, 
unusual 
weight loss, 
vision 
changes, and 
severe 
dizziness 
(Prezioso et 
al., 2016). 
Diuretics Amiloride Treatment of 
kidney-
related 
problems 
Abdominal 
pain, 
shortness of 
breath, 
weakness/ 
heaviness of 
the legs, 
vomiting, 
and 
wheezing 
(McTavish et 
al., 2018). 
Nonsteroidal 
anti-
inflammatory 
drug (NSAIDs) 
Ibuprofen, 
acetaminophen, 
and naproxen 
Acute renal 
colic and 
inhibit pain 
and 
inflammatory 
reactions 
Peptic ulcers, 
renal failure, 
stroke and 
heart disease, 
allergic 
reactions 
(itching, rash, 
swelling), 
sensitivity to 
light (Ticinesi 
et al., 2018). 
Opioid drugs Morphine and 
meperidine 
Management 
of renal colic 
pain and 
perioperative 
pain 
Sedation, 
dizziness, 
nausea and 
vomiting, 
constipation, 
physical 
dependence, 
tolerance, 
and 
respiratory 
depression 
(Primarizky 
et al., 2016). 
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PREVENTION 
Kidney stones disease is a silent killer. Patients at high risk 
of stone recurrence should receive preventive measures 
tailored to the metabolic assessment (Shang et al., 2017). 
Generally, a simple and most important lifestyle change 
to prevent stones disease is to drink 4-6 L 
water/liquids/fluids per day, proper management of 
diet, and the use of medications is required (Ticinesi et al., 
2019). Enough liquid intake reduces urinary saturation 
and dilutes promoters of CaC2O4 crystallization. Thus, 
nutritional management is the best preventive strategy 
against Urolithiasis (Streeper, 2018). The five practical 
steps to prevent kidney stones disease described in Table 
VI. 
Table VI. The five ways adopt in daily routine described may 
help to keep the kidney stones disease (Rodger et 
al., 2018) 
Steps Descriptions 
Healthy and 
balanced diet 
Eat healthy food, plenty of fresh fruits and 
vegetables. Decrease intake of refined foods, 
sugars, fats, and red meats in the meals. For 
those above 40 years of age, consuming less salt 
in the diet may help prevent kidney stones 
(Shavit et al., 2015). 
Physical 
exercise/ 
activity 
At least 30 minutes of regular aerobic exercise 
(swimming, running, cycling, or fast walking) 
maintains normal blood pressure, helps control 
blood sugar, and reduces the risk of developing 
kidney stones (Pickard et al., 2015). 
Maintain a 
bodyweight 
Maintain a healthy or balanced body weight 
with a proper diet, burn calories, and regular 
physical activity plans to achieve and stay at a 
healthy weight (Roudakova & Monga, 2014). 
Stop smoking 
or use tobacco 
products and 
manage 
alcohol intake 
Smoking or use other tobacco products and 
excessive intake amounts of alcohol increase 
the risk of cardiovascular diseases (increase 
blood pressure, cholesterol levels, and heart 
attacks or strokes), which is associated with a 
reduction of higher risk of these severe 
conditions (Pearle et al., 2014). 
Stop the 
overuse of 
NSAIDs 
Do not overuse NSAIDs (Ibuprofen, Aspirin, 
Naproxen, etc.) regularly. NSAIDs are known 
to cause kidney damage and subsequent 
failure, particularly if taken regularly. Consult a 
nephrologist to find the best way to control the 
pain without damaging the kidneys (Scales et 
al., 2016). 
 
CONCLUSION 
Nephrolithiasis and Urolithiasis are among the most 
widely recognized problems which influence the urinary 
system in developing countries like the United States, 
India, Italy, Germany, Scotland, Spain, Sweden, Japan, 
and the remainder of the world. Herbal drugs are used 
for centuries due to its safety, efficacy, cultural 
acceptability, and lesser adverse or side effects as 
compared to Allopathic drugs. The present review article 
deals with measures to be adopted for the potential of 
plants in the management (stone dissolving and expel 
activity) of kidney and urinary stones disease. 
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